deerfield.com / singulargenomics.com Listed by incransom Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People whose personal or professional information sits inside the systems of a major healthcare investment firm now face the practical question of whether that data has left the organisation’s control. On 10 September 2025 the ransomware group known as incransom publicly listed Deerfield Management, claiming it had compromised laboratory systems connected to the firm and removed internal files. The number of individuals affected remains unknown, and the precise contents of the material have not been independently confirmed. For anyone who has worked with, invested through, or supplied data to Deerfield or its related entities, the listing raises concrete concerns about possible exposure of sensitive records.

Public detail is limited to the group’s own claim and the basic description of the firm. No independent verification of the intrusion, the volume of data taken, or the identities of affected people has been released. That uncertainty itself is part of the risk: without clear notification, individuals cannot yet know whether they need to take protective steps.

What happened

According to the listing published by the incransom ransomware group on or around 10 September 2025, the actors claim to have hacked and compromised one of the laboratories belonging to Deerfield Management. The group states that internal files were exfiltrated in a ransomware attack. The listing references the domains deerfield.com and singulargenomics.com. No further technical details—such as the initial access method, the duration of the intrusion, encryption of systems, ransom demands, or confirmation that data has been released—have been disclosed in the available record. The number of people affected is listed as unknown. The claim remains an assertion by the threat actors; it has not been independently verified in the facts provided.

Who is incransom?

Incransom is a ransomware group that operates a public leak site on which it names organisations it claims to have compromised. Like many modern ransomware operations, the group typically follows a double-extortion model: it asserts that it has both encrypted systems and copied data, then threatens to publish the material if a ransom is not paid. Public reporting on the group describes it as targeting a range of sectors and posting victim names, sometimes with sample files or descriptions of stolen data, to increase pressure. The group’s statements about any specific victim, including Deerfield Management, should be treated as claims rather than established fact unless corroborated by the organisation itself or by independent investigation. No additional statements by incransom about this particular incident beyond the laboratory-compromise claim appear in the available record.

Deerfield Management and its sector

Deerfield Management is an American investment firm headquartered in New York City. It focuses on public and private investments in the healthcare and biotechnology industries and is regarded as one of the larger dedicated healthcare investment firms. Organisations of this type routinely handle confidential information about portfolio companies, laboratory research partners, financial transactions, employee records, and sometimes patient-related or clinical data flowing through affiliated research entities. The listing also references singulargenomics.com, consistent with the group’s claim that a laboratory connected to Deerfield was involved. A breach affecting an investment firm active in healthcare and biotechnology is consequential because the data such firms hold can include commercially sensitive research details, personal identifiers of staff and partners, and information that could be used for further targeting or fraud.

What was likely exposed

The available facts state only that internal files were exfiltrated in a ransomware attack. Exact data types, file counts, and whether personal identifiers, financial records, research data, or employee information were among the material are not disclosed. Organisations in the healthcare investment and biotechnology laboratory space typically maintain contracts, due-diligence files, research notes, employee directories, vendor records, and sometimes clinical or genomic-related datasets. Because the precise contents remain unconfirmed, it is not possible to state what was actually taken. The group’s claim that it compromised a laboratory belonging to Deerfield simply indicates that systems holding internal files were allegedly accessed; it does not specify which categories of information left the environment.

Why it matters

For individuals whose data may have been present, the real-world risks include potential misuse of personal or professional information for phishing, identity fraud, or targeted social engineering. Employees, contractors, researchers, and business partners of Deerfield or related laboratories could face follow-on attempts that exploit knowledge of internal relationships or projects. For the organisation itself, the incident raises operational, legal, and reputational considerations common to any claimed ransomware event involving internal files: the need to investigate, notify affected parties where required by law, and assess whether sensitive commercial or research material has been exposed. Because the scale of impact is unknown and the listing is an unverified claim, the full extent of harm cannot yet be measured. Calm monitoring of official communications from Deerfield remains the most reliable source of updates.

If your data was in this claimed breach

If you have a past or present connection to Deerfield Management, its portfolio companies, or laboratories associated with the firm, treat the situation as a possible exposure until clearer information appears. Practical first steps include:

• Monitor financial and credit accounts for unusual activity and consider a fraud alert if you have reason to believe personal identifiers were held.
• Be alert to phishing or social-engineering attempts that reference Deerfield, healthcare investments, or laboratory work.
• Change passwords on any accounts that reused credentials potentially stored in corporate systems, and enable multi-factor authentication where available.
• Watch for official breach notifications from Deerfield or its affiliates rather than relying solely on third-party claims.
• Run a free exposure scan of your email address to check whether your information has already surfaced in known breach datasets.

Public detail on this incident remains limited. Any further confirmed information should come from the organisation itself or from regulatory disclosures. Until then, measured caution is the most useful response.

AICompiled with AI assistance from public sources and published under our editorial standards.